Allspring Global Investments
CGON icon

Allspring Global Investments’s CG Oncology CGON Stock Holding History

Allspring Global Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
+3,553
New +$232K ﹤0.01% 1610

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's CGON Position: Q2 2026 in Review

Allspring Global Investments opened a new position in CG Oncology (CGON) in Q2 2026: 3,553 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #1610 among its holdings.

195 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Allspring Global Investments held 3,553 shares of CG Oncology worth $252K as of Q2 2026.
  • CG Oncology was a new Allspring Global Investments position in Q2 2026.
  • CG Oncology made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1610 holding.
  • 195 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.